Table 2.
First author | Year | Country/racial decent | Study design | Casesa (PDR) | Controlsa (NPDR) | Cases | Controls | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
11b | 12b | 22b | 11b | 12b | 22b | ||||||
−634 G>C (rs2010963) | |||||||||||
Awata [25] | 2002 | Japan (Asian) | Hospital based controls | 70 | 80 | 24 | 30 | 16 | 14 | 51 | 15 |
Uthra [19] | 2008 | India (Asian) | Population based controls | 44 | 87 | 21 | 17 | 3 | 39 | 33 | 7 |
Chun [21] | 2010 | Korea (Asian) | Hospital based controls | 145 | 108 | 48 | 73 | 24 | 37 | 52 | 19 |
| |||||||||||
+936 C/T (rs3025039) | |||||||||||
Awata [25] | 2002 | Japan (Asian) | Hospital based controls | 70 | 80 | 44 | 20 | 6 | 49 | 27 | 4 |
Uthra [19] | 2008 | India (Asian) | Population based controls | 44 | 87 | 35 | 9 | 0 | 76 | 10 | 0 |
Kim [26] | 2009 | Korea (Asian) | Population based controls | 37 | 84 | 15 | 19 | 3 | 40 | 44 | 15 |
PDR: proliferative diabetic retinopathy; NPDR: nonproliferative diabetic retinopathy.
aSample size.
b11: wild-type homozygote; 12: heterozygote; 22: variant homozygote.